Furthermore, PSMA-targeted imaging demonstrates higher sensitivity and specificity than conventional choline-based tracers like 11C-choline and 18F-choline in identifying recurrent prostate cancer, particularly at low PSA levels [61,62]. This evidence concerns the gene FOLH1 and prostate cancer.